Product Description
Dialyzer for postoperative acute renal failure (Sourced from: https://clinicaltrials.gov/ct2/show/NCT00451373)
Mechanisms of Action: Unknown
Novel Mechanism: No
Modality: N/A
Route of Administration: N/A
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: National Taiwan University Hospital
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|
| 31MD03 | N/A |
Unknown status |
Kidney Diseases|Acute Kidney Injury|Sepsis |
None |
2019-03-21 |
Treatments |
Recent News Events
Date |
Type |
Title |
|---|